Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
48.87
-1.06 (-2.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CRISPR Therapeutics AG - Common Shares
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
35
36
Next >
Why CRISPR Therapeutics Stock Is Moving Higher Monday
↗
November 06, 2023
CRISPR Therapeutics AG (NYSE: CRSP) shares are trading higher Monday after the company announced preclinical data for its investigational programs for the
Via
Benzinga
2 Magnificent Growth Stocks That Might Be Badly Mispriced Right Now
↗
November 05, 2023
These two beaten-down growth stocks could be brilliant buys for risk-tolerant investors.
Via
The Motley Fool
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
↗
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
Why CRISPR Therapeutics Stock Charged Northward This Week
↗
November 03, 2023
Gene correction technology took a big step forward this week.
Via
The Motley Fool
CRISPR Therapeutics Stock: Bull vs. Bear
↗
October 21, 2023
Here's the scoop on one of the most widely followed gene-editing stocks on the market.
Via
The Motley Fool
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
↗
November 03, 2023
The meeting went almost as well as could be expected.
Via
The Motley Fool
3 Healthcare Stocks to Buy Hand Over Fist in November
↗
November 03, 2023
Get these stocks while they're cheap.
Via
The Motley Fool
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
↗
November 02, 2023
This stock could be a long-term winner, thanks to its game-changing technology.
Via
The Motley Fool
Why Are Stocks Up Today?
↗
November 01, 2023
Stocks are up today as investors prepare for the most recent information from the Federal Reserve concerning interest rates.
Via
InvestorPlace
Topics
Economy
Why Is Aldeyra Therapeutics (ALDX) Stock Up 40% Today?
↗
November 01, 2023
Aldeyra Therapeutics stock is rising with heavy trading of ALDX shares after signing an exclusive option agreement with AbbVie.
Via
InvestorPlace
Crispr Therapeutics Rallies On Bullish Views Of First-Ever Gene-Editing Drug
↗
November 01, 2023
The agency could soon approve a potential cure for sickle cell disease .
Via
Investor's Business Daily
CRSP Stock Alert: Can CRISPR Therapeutics Short Squeeze Higher?
↗
November 01, 2023
CRSP stock is rallying after an FDA panel appeared to view CRISPR Therapeutics' sickle-cell anemia treatment as safe.
Via
InvestorPlace
AMD, CRISPR Therapeutics, Paycom Software, DraftKings, Tesla: Why These 5 Stocks Are On Investors' Radars Today
↗
October 31, 2023
Major U.S. indices ended in the green on Tuesday, with the Dow gaining nearly 124 points or 0.4% to 33,052.87.
Via
Benzinga
Topics
Stocks
CRSP Stock Halt: CRISPR Trading Halted Ahead of FDA Decision
↗
October 31, 2023
Investors in CRISPR and CRSP stock have certainly been on a wild ride so far this year. Here's what investors need to watch right now.
Via
InvestorPlace
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
↗
October 30, 2023
This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.
Via
The Motley Fool
CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy
↗
October 27, 2023
Although CRISPR Therapeutics may have a breakthrough drug on its hands, regulatory concerns hang over CRSP stock.
Via
InvestorPlace
Questions Surround Vertex/CRISPR's Sickle Cell Gene Therapy As FDA AdComm Meeting Approaches
↗
October 27, 2023
The FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will meet next
Via
Benzinga
Vertex Pharmaceuticals: Buy at the High?
↗
October 26, 2023
Vertex shares have been flying high in recent times.
Via
The Motley Fool
2 Fantastic Growth Stocks to Buy Hand Over Fist
↗
October 26, 2023
These stocks make great bargains today.
Via
The Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
↗
October 25, 2023
Neither has performed well on the stock market this year.
Via
The Motley Fool
3 No-Brainer Stocks to Buy Right Now for Less than $100
↗
October 23, 2023
You can start with a small investment and win big over time.
Via
The Motley Fool
7 Biotech Stocks to Get In Now Before Investors Catch On
↗
October 23, 2023
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.
Via
InvestorPlace
Cathie Wood Is Buying These Top Growth Stocks -- and Both Could Make You Richer Over Time
↗
October 21, 2023
Wood is going all in on gene editing.
Via
The Motley Fool
3 Gene Editing Stocks to Generate Super-Charged Gains
↗
October 18, 2023
As things progress, such techniques may be able to knock out every disease known, creating massive opportunity for gene-editing stocks.
Via
InvestorPlace
Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing
↗
October 18, 2023
The company can begin a pivotal study of its treatment for cardiomyopathy.
Via
Investor's Business Daily
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
↗
October 17, 2023
Via
Benzinga
Cautious Optimism For Bluebird Bio's Sickle Cell Therapy: Analyst Sees Financial Challenges
↗
October 17, 2023
Cantor Fitzgerald initiated coverage on Bluebird Bio Inc (NASDAQ: BLUE), saying sickle cell disorder (SCD) has been a hotbed of development for genetic medicines as the company's lovo-cel marches...
Via
Benzinga
Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst
↗
October 17, 2023
Cantor Fitzgerald has downgraded Editas Medicine Inc (NASDAQ: EDIT) to Neutral from Overw
Via
Benzinga
Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy
↗
October 17, 2023
Cantor Fitzgerald has downgraded CRISPR Therapeutics AG (NASDAQ: CRSP) to Neutral from Ov
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
↗
October 17, 2023
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
